NewsAI-assisted

Veteran Marc Forth Takes the Helm at Jeune Aesthetics

Marc Forth appointed CEO of Jeune Aesthetics to lead next growth phase.

Mrudula Kulkarni
By Mrudula Kulkarni
Managing Editor - Pharma Now
Apr 08, 2025Updated Jun 26, 2025 · 2 min read
Share
Veteran Marc Forth Takes the Helm at Jeune Aesthetics
freepik.com
AI-assisted reporting
Reviewed by Mrudula Kulkarni, Managing Editor - Pharma Now

Jeune Aesthetics, the aesthetics-focused arm of Krystal Biotech, is welcoming seasoned industry leader Marc Forth as its new CEO. With more than 30 years of commercial and executive experience—including key leadership roles in the success of globally recognized brands like BOTOX®—Forth steps into this role as Jeune prepares to scale its innovative gene-delivery-based skincare platform. Having served on Jeune’s board since 2021, Forth is no stranger to the company’s mission to redefine skin rejuvenation at the molecular level.

Forth’s resume is steeped in aesthetics and therapeutic commercialization, from steering AEON Biopharma through clinical development to leading divisions at Allergan that launched transformative products. His deep expertise in consumer engagement and brand building will be crucial as Jeune aims to position itself as a category leader in reversing the biology of aging skin. “I’m energized to lead Jeune into its next chapter and bring truly rejuvenative treatments to people around the world,” said Forth.

TopicsNews
Mrudula Kulkarni
Written by
Mrudula Kulkarni
Managing Editor - Pharma Now

My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.



Discussion

Loading discussion…

More from Pharma News

All stories →